Patents by Inventor Jean-Patrick Joly

Jean-Patrick Joly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteasome inhibiting ?-lactam prodrugs useful for the treatment of cancer and neurodegenerative disorders
    Patent number: 11053249
    Abstract: The present invention relates generally to proteasome inhibiting ?-lactam compounds useful for the treatment of cancer and neurodegenerative disorders. The invention also provides pharmaceutical compositions and extended release formulations of said compounds, and medical uses of said compounds and/or pharmaceutical compositions to treat cancer and neurodegenerative disorders.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: July 6, 2021
    Assignees: Philippe Yves-Remy Simon, VITA API
    Inventors: Philippe Yves-Rémy Simon, Henri Oreal, Gérard Audran, Marvin Schulz, Jean-Patrick Joly, Didier Siri, Anouk Siri
  • Proteasome Inhibiting Beta-Lactam Produrgs Useful for the Treatment of Cancer and Nurodegenerative Disorders
    Publication number: 20200216455
    Abstract: The present invention relates generally to proteasome inhibiting ?-lactam compounds useful for the treatment of cancer and neurodegenerative disorders. The invention also provides pharmaceutical compositions and extended release formulations of said compounds, and medical uses of said compounds and/or pharmaceutical compositions to treat cancer and neurodegenerative disorders.
    Type: Application
    Filed: December 22, 2017
    Publication date: July 9, 2020
    Applicants: Vita Api, Etat Français Représenté Par le Directeur Central du Service de Santé des Armées, Université D'Aix-Marseille, Centre National de la Recherche Scientifique
    Inventors: Philippe Yves-Rémy Simon, Henri Oreal, Gérard Audran, Marvin Schulz, Jean-Patrick Joly, Didier Siri, Anouk Siri
  • Benzene sulfonamide thiazole compounds
    Patent number: 9567310
    Abstract: The present invention relates to compound of general formula (1) wherein R1 represents C6-C10 aryl comprising one or two fused rings, wherein from 2 to 5 carbon atoms may be replaced with a heteroatom selected from O, S and NR6, and eventually substituted with from 5 to 11 substituents selected from R6, halo, CN, NO2, CF3, OCF3, COOR6, OCOR6, SO2NR6R7, CONR6R7, NR6R7, NR6COR7, (CH2)p—NR6R7, (CH2)p—OR6 and (CH2)pSR6, as well as, if appropriate, their pharmaceutically acceptable salts and/or isomers, tautomers, solvates or isotopic variations thereof. The compounds are useful for the treatment of cancers.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: February 14, 2017
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHARCHE MEDICALE), UNIVERSITE NICE SOPHIA ANTIPOLIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Stephane Rocchi, Robert Ballotti, Rachid Benhida, Michael Cerezo, Maria Duca, Jean-Patrick Joly
  • NEW BENZENE SULFONAMIDE THIAZOLE COMPOUNDS
    Publication number: 20150284347
    Abstract: The present invention relates to compound of general formula (1) wherein R1 represents C6-C10 aryl comprising one or two fused rings, wherein from 2 to 5 carbon atoms may be replaced with a heteroatom selected from O, S and NR6, and eventually substituted with from 5 to 11 substituents selected from R6, halo, CN, NO2, CF3, OCF3, COOR6, OCOR6, SO2NR6R7, CONR6R7, NR6R7, NR6COR7, (CH2)p—NR6R7, (CH2)p—OR6 and (CH2)pSR6, as well as, if appropriate, their pharmaceutically acceptable salts and/or isomers, tautomers, solvates or isotopic variations thereof. The compounds are useful for the treatment of cancers.
    Type: Application
    Filed: November 8, 2013
    Publication date: October 8, 2015
    Inventors: Stephane Rocchi, Robert Ballotti, Rachid Benhida, Michael Cerezo, Maria Duca, Jean-Patrick Joly